Yoshio Hosaka

1.1k citations
53 papers · 883 indexed · h-index 16
Topics
Prostate Cancer Treatment and Research (10 papers)Prostate Cancer Diagnosis and Treatment (7 papers)Helicobacter pylori-related gastroenterology studies (6 papers)

In The Last Decade

Yoshio Hosaka

49 papers receiving 851 citations

Peers

Yoshio Hosaka
Comparison fields: 5 of 85
  • Molecular Biology 377
  • Pulmonary and Respiratory Medicine 298
  • Surgery 181
  • Cancer Research 157
  • Plant Science 147
Replace Wenlin Tai with:
Wenlin Tai China
Feng Lü China
Xinming Song China
Tongxin Yang China
Weiqing Wu China
Matthew T. Blahna United States
Akiko Ono Japan
Joanne Pak United States
Jacques Bauer Switzerland
José A. Caparrós‐Martín Australia
Yoshio Hosaka relative to Wenlin Tai China Wenlin Tai's profile →
Citations per field
00.5×10.5×
Wenlin Tai · 1×
Citations per year

Countries citing papers authored by Yoshio Hosaka

Since Specialization
Citations

This map shows the geographic impact of Yoshio Hosaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Hosaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Hosaka more than expected).

Fields of papers citing papers by Yoshio Hosaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshio Hosaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Hosaka. The network helps show where Yoshio Hosaka may publish in the future.

Co-authorship network of co-authors of Yoshio Hosaka

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Hosaka. A scholar is included among the top collaborators of Yoshio Hosaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Hosaka. Yoshio Hosaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 33
4 1
5 15
6 2
7 15
8 28
9 42
10 24
11 51
12 2
13 1
14 0
15 0
16 3
17 2
18 1
19
1
20
1

About Yoshio Hosaka

Yoshio Hosaka is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Rheumatology, having authored 53 papers that have together received 883 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). The work is most often cited by research in Molecular Medicine (74 citations), Cancer Research (157 citations) and Pulmonary and Respiratory Medicine (298 citations). Yoshio Hosaka has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Tadaichi Kitamura, Kazuki Kawabe, Michael M. Lieber, Hisashi Matsushima, George M. Farrow, Leslie M. Rainwater, Tadasuke Ooka, R Sasaki, Hisayo Yamane and Ryutaro Tao. Their work appears in journals such as PLoS ONE, Cancer and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026